In addition, increased serum concentrations of the acute-phase reactants C-reactive proteins (CRP) and high-sensitivity CRP (hs-CRP) are commonly used to monitor inflammation and are strongly associated with metabolic syndrome, atherosclerotic cardiovascular disease, and T2D [3, 4]. This evidence concerns the gene CRP and metabolic syndrome.